The starting line for COVID-19 vaccine development.

Lee, Nelson; McGeer, Allison

Lee, Nelson; McGeer, Allison.

Lee N; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2G3, Canada. Electronic address: laishunn@ualberta.ca.
McGeer A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Sinai Health System, Toronto, ON, Canada.

Lancet ; 395(10240): 1815-1816, 2020 06 13.

Article in English | MEDLINE | ID: covidwho-401264

Subject(s)

Coronavirus Infections; Viral Vaccines; Adenoviridae; COVID-19 Vaccines; Coronavirus Infections/prevention & control; Humans; Vaccines, Synthetic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / Coronavirus Infections Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google